Teva to divest business venture in Japan; Layoffs at Rome Therapeutics 

Plus, news about Cy­cla­cel Phar­ma­ceu­ti­cals, Med­i­ci­No­va and Rev­o­lu­tion Med­i­cines:

Te­va will di­vest its Japan busi­ness ven­ture to pri­vate eq­ui­ty firm: The com­pa­ny

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.